Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hunt

Showing results (611-620 of 670) with videos related to

Pageof 67
Sort By:
Organic & Biomolecular Chemistry|October 15, 2013
A structural and dynamic investigation of the inhibition of catalase by nitric oxideMarco Candelaresi, Andrea Gumiero, Katrin Adamczyk, et al.
American Journal of Preventive Medicine|June 21, 2021
COVID-19 Leads to Accelerated Increases in Children's BMI z-Score Gain: An Interrupted Time-Series StudyR Glenn Weaver, Ethan T Hunt, Bridget Armstrong, et al.
Cancer Research|June 3, 2004
Apoptotic and cytostatic farnesyltransferase inhibitors have distinct pharmacology and efficacy profiles in tumor modelsVeeraswamy Manne, Francis Y F Lee, David K Bol, et al.
Molecular Therapy. Nucleic Acids|March 3, 2025
Enhanced HDR-mediated correction of heterozygous <i>COL7A1</i> mutations for recessive dystrophic epidermolysis bullosaJohn M T Hunt, Alex du Rand, Daniel Verdon, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2018
Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-formMicah T Nelp, Patrick A Kates, John T Hunt, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2004
The synthesis and evaluation of [2.2.1]-bicycloazahydantoins as androgen receptor antagonistsAaron Balog, Mark E Salvati, Weifang Shan, et al.
Molecular Cancer Therapeutics|January 28, 2010
The antiangiogenic activity in xenograft models of brivanib, a dual inhibitor of vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 kinasesRajeev S Bhide, Louis J Lombardo, John T Hunt, et al.
Bioorganic & Medicinal Chemistry Letters|June 11, 2013
Design, synthesis, functional and structural characterization of an inhibitor of N-acetylneuraminate-9-phosphate phosphatase: observation of extensive dynamics in an enzyme/inhibitor complexSoong-Hoon Kim, Keith L Constantine, Gerald J Duke, et al.
Nucleic Acids Research|January 1, 1997
The Protein Information Resource (PIR) and the PIR-International Protein Sequence DatabaseD G George, R J Dodson, J S Garavelli, et al.
Experimental Hematology|January 21, 2000
A new form of Filgrastim with sustained duration in vivo and enhanced ability to mobilize PBPC in both mice and humansG Molineux, O Kinstler, B Briddell, et al.
Pageof 67

Showing results (611-620 of 670) with videos related to

Sort By:
Pageof 67
Organic & Biomolecular Chemistry|October 15, 2013
A structural and dynamic investigation of the inhibition of catalase by nitric oxideMarco Candelaresi, Andrea Gumiero, Katrin Adamczyk, et al.
American Journal of Preventive Medicine|June 21, 2021
COVID-19 Leads to Accelerated Increases in Children's BMI z-Score Gain: An Interrupted Time-Series StudyR Glenn Weaver, Ethan T Hunt, Bridget Armstrong, et al.
Cancer Research|June 3, 2004
Apoptotic and cytostatic farnesyltransferase inhibitors have distinct pharmacology and efficacy profiles in tumor modelsVeeraswamy Manne, Francis Y F Lee, David K Bol, et al.
Molecular Therapy. Nucleic Acids|March 3, 2025
Enhanced HDR-mediated correction of heterozygous <i>COL7A1</i> mutations for recessive dystrophic epidermolysis bullosaJohn M T Hunt, Alex du Rand, Daniel Verdon, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2018
Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-formMicah T Nelp, Patrick A Kates, John T Hunt, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2004
The synthesis and evaluation of [2.2.1]-bicycloazahydantoins as androgen receptor antagonistsAaron Balog, Mark E Salvati, Weifang Shan, et al.
Molecular Cancer Therapeutics|January 28, 2010
The antiangiogenic activity in xenograft models of brivanib, a dual inhibitor of vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 kinasesRajeev S Bhide, Louis J Lombardo, John T Hunt, et al.
Bioorganic & Medicinal Chemistry Letters|June 11, 2013
Design, synthesis, functional and structural characterization of an inhibitor of N-acetylneuraminate-9-phosphate phosphatase: observation of extensive dynamics in an enzyme/inhibitor complexSoong-Hoon Kim, Keith L Constantine, Gerald J Duke, et al.
Nucleic Acids Research|January 1, 1997
The Protein Information Resource (PIR) and the PIR-International Protein Sequence DatabaseD G George, R J Dodson, J S Garavelli, et al.
Experimental Hematology|January 21, 2000
A new form of Filgrastim with sustained duration in vivo and enhanced ability to mobilize PBPC in both mice and humansG Molineux, O Kinstler, B Briddell, et al.
Pageof 67